We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$335M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$140M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$82.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.4M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHAA
3976
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$11.4K ﹤0.01%
1,112
+1
+0.1% +$10
ALOT icon
3977
AstroNova
ALOT
$227M
$11.4K ﹤0.01%
788
-311
-28% -$4.63K
GLUE icon
3978
Monte Rosa Therapeutics
GLUE
$1.35B
$11.4K ﹤0.01%
1,668
-676
-29% -$4.37K
IHRT icon
3979
iHeartMedia
IHRT
$464M
$11.4K ﹤0.01%
3,136
-270
-8% -$897
STRR
3980
Star Equity Holdings
STRR
$37.5M
$11.4K ﹤0.01%
530
-259
-33% -$5.5K
LFMD icon
3981
LifeMD
LFMD
$167M
$11.4K ﹤0.01%
2,623
-4,295
-62% -$9.54K
RKDA icon
3982
Arcadia Biosciences
RKDA
$1.24M
$11.4K ﹤0.01%
2,932
+2,930
+146,500% +$15.6K
ERNA icon
3983
Eterna Therapeutics
ERNA
$5.02M
$11.4K ﹤0.01%
+13
New +$13.1K
TECX
3984
Tectonic Therapeutic
TECX
$664M
$11.4K ﹤0.01%
996
+466
+88% +$5.27K
CXM icon
3985
Sprinklr
CXM
$1.65B
$11.4K ﹤0.01%
821
-12,090
-94% -$156K
CVRX icon
3986
CVRx
CVRX
$78.3M
$11.3K ﹤0.01%
735
-2,241
-75% -$27.3K
CYTH
3987
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$11.3K ﹤0.01%
7,137
-4,816
-40% -$6.15K
NPKI
3988
NPK International
NPKI
$1.18B
$11.3K ﹤0.01%
2,167
-2,256
-51% -$9.34K
CXDO icon
3989
Crexendo
CXDO
$217M
$11.3K ﹤0.01%
6,437
+3,595
+126% +$5.76K
KF
3990
Korea Fund
KF
$266M
$11.3K ﹤0.01%
+489
New +$10.9K
MYSE
3991
Myseum.AI Inc
MYSE
$13.1M
$11.3K ﹤0.01%
2,070
+76
+4% +$346
LMNR icon
3992
Limoneira
LMNR
$250M
$11.3K ﹤0.01%
726
-6,843
-90% -$113K
AMTB icon
3993
Amerant Bancorp
AMTB
$1.14B
$11.3K ﹤0.01%
657
-1,782
-73% -$33.2K
XFOR icon
3994
X4 Pharmaceuticals
XFOR
$425M
$11.3K ﹤0.01%
194
+167
+619% +$8.58K
SPIR icon
3995
Spire Global
SPIR
$540M
$11.3K ﹤0.01%
2,737
+830
+44% +$4.42K
GSG icon
3996
iShares S&P GSCI Commodity-Indexed Trust
GSG
$932M
$11.3K ﹤0.01%
+578
New +$11.4K
SNCY
3997
DELISTED
Sun Country Airlines
SNCY
$11.3K ﹤0.01%
501
-537
-52% -$10.3K
ACCO icon
3998
Acco Brands
ACCO
$399M
$11.3K ﹤0.01%
2,161
-2,368
-52% -$11.9K
LCTX icon
3999
Lineage Cell Therapeutics
LCTX
$268M
$11.2K ﹤0.01%
7,976
-1,992
-20% -$2.75K
VIVS
4000
VivoSim Labs
VIVS
$1.15M
$11.2K ﹤0.01%
555
+216
+64% +$4.87K
158 159
160
161 162

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.